- IT stocks muted as US may announce foreign workers' visa restrictions today
- ICICI Bank, SBI: Fitch revises IDR outlook. Time to sell these stocks?
- Cipla hits 52-wk high on launch of generic remdesivir for Covid-19 patients
- RIL gains 2.5%, hits fresh record high; stock zooms over 100% in 3 months
- ICICI Bank gains over 3% after paring stake in ICICI Prudential Life
- Glenmark Pharma zooms 40% on launch of Favipiravir, a potential Covid drug
- Stocks to watch: Glenmark, Cipla, IT stocks, HDFC, Sudarshan Chemical Ind
- Market Ahead, June 22: Top factors that could guide markets this week
- MARKET LIVE: Sensex off high, up 150 pts; Glenmark Pharma zooms 40%
- Eight of top 10 firms add Rs 1.76 trillion in m-cap; Reliance leads rally
MARKET LIVE: Sensex off high, up 200 pts; Glenmark Pharma zooms 40%
Catch all the live market updates here
Topics
MARKET LIVE | Markets | Dalmia Bharat
SI Reporter |
Last Updated at June 22, 2020 12:22 IST
EVENT HIGHLIGHTS
The Bombay Stock Exchange (BSE) building in Mumbai
The Indian markets were were trading half a per cent higher but off the day's top on Monday, lifted by pharma and bank stocks.
The S&P BSE Sensex was up 220 points and was marginally below the 35,000 level. The Nifty50 index was hovering over 10,300-mark. Bajaj twins (Bajaj Finserv, Bajaj Finance) both shot up 5 per cent each and were the top Sensex gainers. Besides, IndusInd Bank and Bajaj Auto also rose over 2 per cent each. Reliance Industries climbed another 2 per cent and hit $150 billion m-capitalistaion.
Among other stocks, Glenmark Pharmaceutials surged 40 per cent to Rs 572.70 after it became the first Indian company to secure drug regulator’s nod on manufacturing and marketing the antiviral drug, Favipiravir in India. READ MORE
Meanwhile, Reliance Industries (RIL) hit a fresh all-time high of Rs 1,804, up 2.5 per cent, on the BSE on Monday, having surged 12 per cent in the past three trading sessions as the company become net debt-free ahead of its March 2021 deadline. READ MORE
The trend among Nifty sectoral indices was all green, except the Nifty IT index, led by Nifty Pharma index, up 1.8 per cent.
Broader indices outperformed the benchmarks and both the S&P BSE MidCap index as well as the SmallCap index were trading 1 per cent higher each.
The S&P BSE Sensex was up 220 points and was marginally below the 35,000 level. The Nifty50 index was hovering over 10,300-mark. Bajaj twins (Bajaj Finserv, Bajaj Finance) both shot up 5 per cent each and were the top Sensex gainers. Besides, IndusInd Bank and Bajaj Auto also rose over 2 per cent each. Reliance Industries climbed another 2 per cent and hit $150 billion m-capitalistaion.
Among other stocks, Glenmark Pharmaceutials surged 40 per cent to Rs 572.70 after it became the first Indian company to secure drug regulator’s nod on manufacturing and marketing the antiviral drug, Favipiravir in India. READ MORE
Meanwhile, Reliance Industries (RIL) hit a fresh all-time high of Rs 1,804, up 2.5 per cent, on the BSE on Monday, having surged 12 per cent in the past three trading sessions as the company become net debt-free ahead of its March 2021 deadline. READ MORE
The trend among Nifty sectoral indices was all green, except the Nifty IT index, led by Nifty Pharma index, up 1.8 per cent.
Broader indices outperformed the benchmarks and both the S&P BSE MidCap index as well as the SmallCap index were trading 1 per cent higher each.
Results today
On the results front, a total of 61 companies including Dhanlaxmi Bank and AIA Engineering, are scheduled to announce their March quarter earnings.
CATCH ALL THE LIVE UPDATES
Auto Refresh
Load More
Copyrights © 2020 Business Standard Pvt Ltd. All rights reserved.